Dr. Abraham Morgentaler

Is that more or less accurate? What an interesting idea. So the question I think you're asking about is what about trying to give them a little daily boost without really changing much? I think that's a very interesting idea. I'm not aware that anybody is trying that yet or has reported any data on it, but it's a very interesting idea.

Is that more or less accurate? What an interesting idea. So the question I think you're asking about is what about trying to give them a little daily boost without really changing much? I think that's a very interesting idea. I'm not aware that anybody is trying that yet or has reported any data on it, but it's a very interesting idea.

Yeah. You know, so one of the things that the orals have transformed is the concept that you have to have a continually high level of testosterone to get the benefits. And clearly that's not true. And the safety seems to be improved, the safety profile, by having levels that fluctuate some during the day, returning close to or even to baseline. So for example...

Yeah. You know, so one of the things that the orals have transformed is the concept that you have to have a continually high level of testosterone to get the benefits. And clearly that's not true. And the safety seems to be improved, the safety profile, by having levels that fluctuate some during the day, returning close to or even to baseline. So for example...

Yeah. You know, so one of the things that the orals have transformed is the concept that you have to have a continually high level of testosterone to get the benefits. And clearly that's not true. And the safety seems to be improved, the safety profile, by having levels that fluctuate some during the day, returning close to or even to baseline. So for example...

You know, many of the risks of testosterone that we used to talk about probably aren't accurate anymore. You know, we had the Traverse trial, the biggest randomized control trial ever that I think disproved the idea that cardiovascular risks were increased with testosterone. They were not compared to placebo. And the same is true for prostate cancer.

You know, many of the risks of testosterone that we used to talk about probably aren't accurate anymore. You know, we had the Traverse trial, the biggest randomized control trial ever that I think disproved the idea that cardiovascular risks were increased with testosterone. They were not compared to placebo. And the same is true for prostate cancer.

You know, many of the risks of testosterone that we used to talk about probably aren't accurate anymore. You know, we had the Traverse trial, the biggest randomized control trial ever that I think disproved the idea that cardiovascular risks were increased with testosterone. They were not compared to placebo. And the same is true for prostate cancer.

I think the data is now becoming overwhelming that testosterone does not increase the risk of prostate cancer. But one of the things we've always worried about is polycythemia, the risk of getting a high hematocrit, which can happen in up to 20% of men who do injections. And the rate with the orals appears to be more in the 2% to 3% range.

I think the data is now becoming overwhelming that testosterone does not increase the risk of prostate cancer. But one of the things we've always worried about is polycythemia, the risk of getting a high hematocrit, which can happen in up to 20% of men who do injections. And the rate with the orals appears to be more in the 2% to 3% range.

I think the data is now becoming overwhelming that testosterone does not increase the risk of prostate cancer. But one of the things we've always worried about is polycythemia, the risk of getting a high hematocrit, which can happen in up to 20% of men who do injections. And the rate with the orals appears to be more in the 2% to 3% range.

It doesn't happen as much, almost certainly because the levels of testosterone aren't sustained at the high level, and yet people still get the benefits.

It doesn't happen as much, almost certainly because the levels of testosterone aren't sustained at the high level, and yet people still get the benefits.

It doesn't happen as much, almost certainly because the levels of testosterone aren't sustained at the high level, and yet people still get the benefits.

So to be able to have levels of testosterone that provide men with whatever it is they need, like the testosterone level they need for sex drive, for vitality, for mood, and at the same time to have fewer of the adverse effects or potentially fewer, that's a pretty good trade-off.

So to be able to have levels of testosterone that provide men with whatever it is they need, like the testosterone level they need for sex drive, for vitality, for mood, and at the same time to have fewer of the adverse effects or potentially fewer, that's a pretty good trade-off.

So to be able to have levels of testosterone that provide men with whatever it is they need, like the testosterone level they need for sex drive, for vitality, for mood, and at the same time to have fewer of the adverse effects or potentially fewer, that's a pretty good trade-off.

Yeah, so the words of wisdom is don't be afraid. Realize that the goalposts have shifted a lot over the last 30 years. It used to be you can't do this ever, give testosterone to anybody. Then it became you can't do it to anybody who were worried about prostate cancers, had prostate cancer. And now that's clearly not true, right?

Yeah, so the words of wisdom is don't be afraid. Realize that the goalposts have shifted a lot over the last 30 years. It used to be you can't do this ever, give testosterone to anybody. Then it became you can't do it to anybody who were worried about prostate cancers, had prostate cancer. And now that's clearly not true, right?

Yeah, so the words of wisdom is don't be afraid. Realize that the goalposts have shifted a lot over the last 30 years. It used to be you can't do this ever, give testosterone to anybody. Then it became you can't do it to anybody who were worried about prostate cancers, had prostate cancer. And now that's clearly not true, right?